Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ING Groep NV (ING) vs InMode Ltd (INMD) Price & Performance

ING Groep NVTrade
InMode LtdTrade

Price performance (Past 24H)

Key statistics

ING Groep NV vs InMode Ltd — how do they compare? ING Groep NV trades at $33.09 (market cap $96.81B), while InMode Ltd trades at $14.07 (market cap $806.05M). The key difference: ING Groep NV is far larger — about 120.1× InMode Ltd's market cap, and ING Groep NV pays a 3.9% dividend while InMode Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold ING Groep NV for 93 Days and InMode Ltd for 29 Days on average.

INGINMD
Market Cap
$96.81B$806.05M
Volume
2,635,505511,446
Sector
FinancialsHealth
52-Week High
$37.27$16.62
52-Week Low
$23.66$12.76
Typical Hold Time
93 Days29 Days
Enterprise Value
$236.31B$309.39M
Dividend Yield
3.9%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ING Groep NV

ING stock trades at $33.43, down 4.21% with bearish technical signals despite strong fundamentals. The company has beaten earnings estimates for three consecutive quarters with Q2 2026 EPS of $0.79 versus $0.75 expected. Revenue growth remains steady at $22.9B in 2025 with a robust 28.34% net margin. Analyst consensus is strongly bullish with 11 buy ratings and no sell recommendations.

The stock presents a value opportunity with a reasonable P/E of 13.09 and strong profitability metrics, though negative cash flow trends and regulatory challenges in Australia warrant monitoring. Management's raised ROE target above 16% for 2027 signals confidence in continued operational improvement and strategic execution.

InMode Ltd

INMD trades at $14.01, showing minimal daily movement with a 0.14% gain. The stock faces bearish technical signals despite attractive valuation metrics including a P/E of 11.58 and EV/EBITDA of 4.43. Recent earnings show mixed results with Q2 2026 beating expectations but Q1 2026 missing, while the company faces shareholder activism from Steel Partners' $16.75 per share acquisition offer. Revenue guidance for 2026 remains stable at $365M-$375M.

The investment case balances strong profitability margins against technical weakness and activist pressure. With 45% analyst buy ratings and no sell recommendations, fundamental value appears intact, but near-term price action suggests caution. Key catalysts include Q3 2026 earnings and resolution of the acquisition proposal, while risks include execution challenges and macroeconomic headwinds affecting aesthetic medicine demand.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ING
100% Buy0% Sell
Avg holding period · 93 Days
INMD

No sentiment data available yet.

About ING Groep NV

The merger of the Dutch postal bank and NN Insurance in 1991 created ING. Through a series of further acquisitions ING build up a global footprint. The 2008 financial crisis forced ING to seek government support--a precondition of which was that ING should separate its banking and insurance activities, which saw ING revert to being solely a bank. ING has market- leading banking operations in the Netherlands and Belgium, and a range of digital banks across Europe and Australia. Its global wholesale banking operation is primarily focused on lending.

Read more on ING →

About InMode Ltd

InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.

Read more on INMD →